Soc. Generale Knock-Out FRE/ DE000CJ4M1X3 /
5/31/2023 9:46:14 PM | Chg.+0.050 | Bid5/31/2023 | Ask5/31/2023 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
2.720EUR | +1.87% | 2.720 Bid Size: 10,000 |
2.730 Ask Size: 10,000 |
FRESENIUS SE+CO.KGAA... | 52.8834 EUR | 12/31/2078 | Put |
GlobeNewswire
6/11/2021
UPDATE -- Humacyte Expands Strategic Global Partnership with Fresenius Medical Care
GlobeNewswire
11/11/2019
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fresenius Medica...
GlobeNewswire
11/4/2019
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fresenius Medica...
GlobeNewswire
10/29/2019
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Fresenius Medica...
GlobeNewswire
10/23/2019
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fresenius Medic...
GlobeNewswire
6/9/2017
KISSEI TO MARKET AVACOPAN IN JAPAN FOR VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA
GlobeNewswire
1/27/2011
Swedish Orphan Biovitrum agrees with Fresenius Biotech to distribute Removab®